financetom
Business
financetom
/
Business
/
Saudi Aramco first-quarter net profit slides 25% as oil prices fall
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Saudi Aramco first-quarter net profit slides 25% as oil prices fall
May 12, 2020 4:36 AM

Saudi Arabian state oil giant Aramco on Tuesday reported a 25% fall in first-quarter net profit, below analyst estimates, hurt by lower crude oil prices as the coronavirus slashed demand.

Brent crude prices fell 65% in the first quarter, before OPEC+ producers agreed to cut oil supply by a record 9.7 million barrel per day starting from May to help shore up prices and curb oversupply. Net profit fell to 62.48 billion riyals ($16.64 billion) after zakat and tax for the quarter to March 31 from 83.29 billion a year earlier.

Analysts had expected a profit of $17.8 billion, according to the mean estimate from Egyptian investment bank EFG-Hermes, Saudi Arabia's Al Rajhi Capital and Dubai-based Arqaam Capital.

Aramco said the results reflected "lower crude oil prices, as well as declining refining and chemicals margins and inventory re-measurement losses."

"Looking ahead to the remainder of 2020, we expect the impact of the COVID-19 pandemic on global energy demand and oil prices to weigh on our earnings," Aramco's CEO Amin Nasser said in a statement.

Aramco has kept its oil output at around 9.7 million barrels per day during the first three months of the year under an OPEC+ supply cut pact, before opening the oil taps in April after the collapse of earlier supply cut talks in early March.

The world's top oil producing company, which went public last year, has said total dividends of $13.4 billion were paid in the first quarter, in respect of the fourth quarter of 2019. Dividends of $18.75 billion will be paid in the second quarter.

Aramco's cash flows from operating activities, stood at $22.4 billion in the first quarter, compared to $24.5 billion in the same period of 2019, the company said.

The national oil giant plans to acquire a stake in Saudi petrochemical maker SABIC for around $70 billion, though sources told Reuters this week that the deal was likely to be restructured with the slump in oil prices due to the coronavirus.

Aramco said earlier on Tuesday that its planned acquisition of a 70% equity stake in petrochemical maker SABIC is on track to close in the second quarter.

First Published:May 12, 2020 1:36 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ultragenyx Pharmaceutical Begins Biologics License Application for Glycogen Storage Disease Gene Therapy
Ultragenyx Pharmaceutical Begins Biologics License Application for Glycogen Storage Disease Gene Therapy
Aug 18, 2025
08:23 AM EDT, 08/18/2025 (MT Newswires) -- Ultragenyx Pharmaceutical ( RARE ) said Monday it initiated a rolling submission of a biologics license application for its DTX401 AAV gene therapy as treatment for glycogen storage disease Type Ia with the US Food and Drug Administration. The company said it aims to complete the full application, including submission of the chemistry,...
Bayer settles Sky Valley cases over chemical PCB
Bayer settles Sky Valley cases over chemical PCB
Aug 18, 2025
Aug 18 (Reuters) - Bayer said on Monday its Monsanto unit reached agreements in principle with more than 200 plaintiffs to resolve the so-called Sky Valley Education Center product liability cases related to the chemical PCB. Bayer said in its statement that the terms of the agreements over environmental pollution with PCB, short for polychlorinated biphenyls, were confidential and subject...
Plus Therapeutics Says Data Shows Reyobiq in Leptomeningeal Metastases Has Promising Efficacy Signal
Plus Therapeutics Says Data Shows Reyobiq in Leptomeningeal Metastases Has Promising Efficacy Signal
Aug 18, 2025
08:22 AM EDT, 08/18/2025 (MT Newswires) -- Plus Therapeutics ( PSTV ) said Monday that data from an early-stage trial using Reyobiq to treat leptomeningeal metastases, a kind of cancer, is feasible, has a manageable safety profile, and shows a promising efficacy signal. The study involved 29 patients in six cohorts who received a different dosage in each one, the...
Catheter Precision Receives UK Approval for Suture Retention Device
Catheter Precision Receives UK Approval for Suture Retention Device
Aug 18, 2025
08:24 AM EDT, 08/18/2025 (MT Newswires) -- Catheter Precision ( VTAK ) said Monday that it has received registration and approval in the UK for its LockeT suture retention device, allowing it to launch sales in the nation. Catheter Precision ( VTAK ) said it has entered into an agreement with UK-based HC21 to distribute LockeT. LockeT received a CE...
Copyright 2023-2026 - www.financetom.com All Rights Reserved